期刊
PEDIATRIC RESEARCH
卷 71, 期 5, 页码 590-597出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/pr.2012.6
关键词
-
类别
资金
- Fondo de Investigacion Sanitaria [FISPS09/02618, INTRASALUD PI09/02029, FIS/PI061505, CP07/00117, FIS06/00176, CD10/00382]
- Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [REDRISRD06/0006/0035]
- Fundacion Caja Navarra
- Proyecto de Excelencia, Junta de Andalucia [P06-CTS-01579]
- Consejeria de Salud, Servicio Andaluz de Salud [PI0366/07]
INTRODUCTION: Current advances in neonatology have improved survival among preterm and low-birth-weight infants. However, the risk of neonatal death in preterm infants is much greater than in full-term neonates and is frequently associated with infections. METHODS: Little is known about the immune status of preterm neonates; therefore, we analyzed the frequency and absolute counts of different immune populations in 211 cord blood samples taken from very-preterm to full-term neonates. RESULTS: We found that absolute counts of all the immune subsets analyzed (i.e., monocytes, granulocytes, B cells, natural killer (NK) cells, CD4+, and CD8(+) T cells) were markedly lower in preterm infants than in full-term infants. Surprisingly, we observed that regulatory T cells (Tregs) were the only cell subset that did not decrease in preterm infants, and their frequency was even higher than in full-term infants. DISCUSSION: Tregs are crucial to maternal fetal tolerance, but their suppressive role could be also implicated in the leukopenia observed in preterm infants. We did not observe differences in thymic function, but we found that plasma levels of interleukin (IL)-7 and the frequency of its receptor were significantly decreased in preterm infants. Our results could help to identify leukopenia and to implement immune therapies that significantly diminish mortality in preterm neonates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据